-
Allegra tackles allergies, OTC rivals this spring
In the year leading up to the switch of Allegra, Sanofi generated $214.2 million in U.S. prescription sales of Allegra, largely due to the generic competition against its Allegra D formulation. Now Sanofi is looking to virtually match those annual sales figures within the much more profitable nonprescription venue with the company’s successful switch from prescription to OTC this spring.
-
Digital coupon wave: Clipping to surfing
Couponing is digitizing.
Although printed circulars remain the workhorse of the nation’s coupon distribution system, a growing share of the coupons consumers are handing cashiers are emerging from online distribution sources and are being printed out at home. A smaller but growing segment also is being handled exclusively through electronic means via smartphones and mobile technology.